Burnout y participación de las tutoras clínicas españolas en el aprendizaje de los estudiantes de enfermería. Proyecto de investigación

Trabajo fin de grado en EnfermeríaIntroducción: Existe una amplia incidencia del síndrome de Burnout en la población de enfermeras de España. A pesar de que se han descrito múltiples factores de riesgo y consecuencias del burnout en la literatura no se han encontrado estudios específicos sobre la incidencia de burnout entre las tutoras clínicas de enfermería. Las tutoras clínicas son enfermeras que asumen de forma voluntaria la responsabilidad sobre el aprendizaje práctico-clínico de los estudiantes del Grado en Enfermería. Sin embargo se han encontrado pocos estudios que evalúen su participación en la tutela de los estudiantes y ninguno que evalúe la relación entre el burnout y la participación en la tutela. Objetivo: Explorar la relación entre el nivel de burnout y el nivel de participación en la tutela en las enfermeras tutoras clínicas de los hospitales y centros de atención primaria asociados a la Universidad Autónoma de Madrid. Metodología: Estudio de tipo cuantitativo, observacional, transversal y analítico utilizando el Maslach Burnout Inventory y el Cuestionario Implicación Motivación Satisfacción Obstáculos y Compromiso (IMSOC). La población de estudio son las enfermeras tutoras clínicas de los hospitales y centros de atención primaria asignados a la Universidad Autónoma de Madrid (n=360), que participan en las Prácticas Tuteladas I y Prácticas Tuteladas III, en el primer semestre del curso 2018-19. Las relaciones entre burnout y participación en la tutela serán exploradas en el análisis de datos.Background: Wide incidence of Burnout syndrome has been found in the population of nurses in Spain. Despite the fact that multiple risk factors and consequences of burnout have been described in the literature, no studies have been found about incidence of burnout in clinical mentors of nursing students. The clinical mentor is a nurse who assumes the responsibility over practical-clinical learning of students from Nursing Degree and none that evaluates the relationship between burnout and participation in mentorship. Burnout y participación de las tutoras clínicas españolas en el aprendizaje de los estudiantes de enfermería. Proyecto de investigación 6 Objetive: To explore the relationship between the level of burnout and the level of participation in mentoring of nurses who are clinical mentors in the hospitals and primary care centers which are assigned to Autonomous University of Madrid. Methods: This quantitative, observational, cross-sectional and analytic study is going to be conduce by applying the validated Maslach Burnout Inventory and Involvement, Motivation, Satisfaction, Obstacles and Commitment (IMSOC) questionnaires. The sample will include 360 nurses who are clinical mentors in hospitals and primary care centers assigned to Autonomous University of Madrid an participate in the courses Clinical Internship I and Clinical Internship III next year. The relationship between burnout and participation in mentorship will be explored in analysis data

Alcohol Use and Sexual Violence among Nursing Students in Catalonia, Spain: A Multicentre Cross-sectional Study

Background: Sexual violence (SV) has become common in universities for reasons related to unwanted social/peer pressures regarding alcohol/drug use and sexual activities. Objectives: To identify perceptions of SV and alcohol use and estimate prevalence among nursing students in Catalonia, Spain. (2) Methods: Observational descriptive cross-sectional study of a convenience sample of nursing students attending public universities. (3) Results: We recruited 686 students (86.11% women), who reported as follows: 68.7% had consumed alcohol, 65.6% had been drunk at least once in the previous year, 62.65% had experienced blackouts and 25.55% had felt pressured to consume alcohol. Drunkenness and blackouts were related (p < 0.000). Of the 15.6% of respondents who had experienced SV, 47.7% experienced SV while under the influence of alcohol and were insufficiently alert to stop what was happening, while 3.06% reported rape. SV was more likely to be experienced by women (OR: 2.770; CI 95%: 1.229-6.242; p = 0.014), individuals reporting a drunk episode in the previous year (OR: 2.839; 95% CI: 1.551-5.197; p = 0.001) and individuals pressured to consume alcohol (OR: 2.091; 95% CI: 1.332-3.281; p = 0.001). (4) Conclusions: Nursing instructors need to raise student awareness of both the effects of alcohol use and SV, so as to equip these future health professionals with the knowledge and skills necessary to deal with SV among young people

Treatment with tocilizumab or corticosteroids for COVID-19 patients with hyperinflammatory state: a multicentre cohort study (SAM-COVID-19)

Objectives: The objective of this study was to estimate the association between tocilizumab or corticosteroids and the risk of intubation or death in patients with coronavirus disease 19 (COVID-19) with a hyperinflammatory state according to clinical and laboratory parameters. Methods: A cohort study was performed in 60 Spanish hospitals including 778 patients with COVID-19 and clinical and laboratory data indicative of a hyperinflammatory state. Treatment was mainly with tocilizumab, an intermediate-high dose of corticosteroids (IHDC), a pulse dose of corticosteroids (PDC), combination therapy, or no treatment. Primary outcome was intubation or death; follow-up was 21 days. Propensity score-adjusted estimations using Cox regression (logistic regression if needed) were calculated. Propensity scores were used as confounders, matching variables and for the inverse probability of treatment weights (IPTWs). Results: In all, 88, 117, 78 and 151 patients treated with tocilizumab, IHDC, PDC, and combination therapy, respectively, were compared with 344 untreated patients. The primary endpoint occurred in 10 (11.4%), 27 (23.1%), 12 (15.4%), 40 (25.6%) and 69 (21.1%), respectively. The IPTW-based hazard ratios (odds ratio for combination therapy) for the primary endpoint were 0.32 (95%CI 0.22-0.47; p < 0.001) for tocilizumab, 0.82 (0.71-1.30; p 0.82) for IHDC, 0.61 (0.43-0.86; p 0.006) for PDC, and 1.17 (0.86-1.58; p 0.30) for combination therapy. Other applications of the propensity score provided similar results, but were not significant for PDC. Tocilizumab was also associated with lower hazard of death alone in IPTW analysis (0.07; 0.02-0.17; p < 0.001). Conclusions: Tocilizumab might be useful in COVID-19 patients with a hyperinflammatory state and should be prioritized for randomized trials in this situatio